Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hims & Hers Health, Inc. (HIMS : NYSE)
 
 • Company Description   
Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco.

Number of Employees: 1,637

 
 • Price / Volume Information   
Yesterday's Closing Price: $47.98 Daily Weekly Monthly
20 Day Moving Average: 44,114,192 shares
Shares Outstanding: 223.83 (millions)
Market Capitalization: $10,739.44 (millions)
Beta: 2.02
52 Week High: $72.98
52 Week Low: $13.47
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -14.82% -18.61%
12 Week 76.20% 50.50%
Year To Date 98.43% 85.86%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2269 CHESTNUT STREET SUITE 523
-
SAN FRANCISCO,CA 94123
USA
ph: 415-851-0195
fax: -
investors@forhims.com http://www.hims.com
 
 • General Corporate Information   
Officers
Andrew Dudum - Chief Executive Officer and Director
Oluyemi Okupe - Chief Financial Officer
Irene Becklund - Senior Vice President; Controller
Deborah Autor - Director
Patrick H. Carroll - Director

Peer Information
Hims & Hers Health, Inc. (HLIS)
Hims & Hers Health, Inc. (AZTA)
Hims & Hers Health, Inc. (APYI)
Hims & Hers Health, Inc. (RNVA)
Hims & Hers Health, Inc. (HMSY)
Hims & Hers Health, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 433000106
SIC: 8011
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/04/25
Share - Related Items
Shares Outstanding: 223.83
Most Recent Split Date: (:1)
Beta: 2.02
Market Capitalization: $10,739.44 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.19 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.74 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 36.53% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/04/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 64.44
Trailing 12 Months: 111.58
PEG Ratio: 1.76
Price Ratios
Price/Book: 19.53
Price/Cash Flow: 136.24
Price / Sales: 6.02
EPS Growth
vs. Year Ago Period: 300.00%
vs. Previous Quarter: 81.82%
Sales Growth
vs. Year Ago Period: 110.67%
vs. Previous Quarter: 21.80%
ROE
06/30/25 - -
03/31/25 - 22.75
12/31/24 - 16.17
ROA
06/30/25 - -
03/31/25 - 15.51
12/31/24 - 11.73
Current Ratio
06/30/25 - -
03/31/25 - 1.59
12/31/24 - 1.79
Quick Ratio
06/30/25 - -
03/31/25 - 1.32
12/31/24 - 1.50
Operating Margin
06/30/25 - -
03/31/25 - 5.83
12/31/24 - 4.45
Net Margin
06/30/25 - -
03/31/25 - 9.24
12/31/24 - 8.56
Pre-Tax Margin
06/30/25 - -
03/31/25 - 6.71
12/31/24 - 4.86
Book Value
06/30/25 - -
03/31/25 - 2.46
12/31/24 - 2.16
Inventory Turnover
06/30/25 - -
03/31/25 - 7.12
12/31/24 - 6.60
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©